BioXcel
在场
高管
查看带有其 16 名主要高管的组织结构图
BioXcel 搜索最多的简介
高管在BioXcel变化
- Pascal Borderies, Vice President, Medical & Scientific Affairs Immuno-Oncology, 已经离开公司 (新闻发布的2024六月13号).
创建提醒
跟踪 BioXcel 的高管变动
生物技术
BioXcel 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
BioXcel 的最新新闻稿
- BioXcel Therapeutics to Highlight Novel Approaches in AI-Based Drug Candidate Discovery and Development and Advances in Neuroscience Portfolio at Virtual R&D Day :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics to Present Updates from Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2021 ESMO Congress :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics to Host Virtual R&D Day on September 23, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Operational Highlights :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics Announces Proposed Public Offering of Common Stock :: BioXcel Therapeutics, Inc. (BTAI)
- BioXcel Therapeutics to Host Virtual Commercial Day on June 25, 2021 :: BioXcel Therapeutics, Inc. (BTAI)
- View more press releases Close
通过电子邮件
